Open App
Company / Named in our posts

Context Therapeutics Inc..

Follow Context Therapeutics Inc.

A biopharmaceutical company advancing medicines for solid tumors.[1]

01Deal
01

Deals on Carrywatch

Every deal that names Context Therapeutics Inc., and its role in each.

Context Therapeutics Inc. / Link

Context Therapeutics buys CT-95 assets from Link assignment entity

See deal details
02

Deal Web

Context Therapeutics Inc. and 0 firms it shares a posted deal with, and the path to any other firm.

03

Financials

5 fiscal years of figures as Context Therapeutics Inc. reported them.

04

News

Loading headlines.

05

Sources

As of 24 Oct 2026.

  1. 01
    Context Therapeutics Acquires Phase 1-ready T cell Engager CT-95

    U.S. Securities and Exchange Commission · Researched 24 Oct 2026

Deal posts naming Context Therapeutics Inc.:

  1. P01